SRx Health Solutions Inc. (SRXH) AI Stock Analysis
SRXH AI stock analysis summary
AI ResearchSRx Health Solutions Inc. (SRXH) is a North Palm Beach-based company operating an AI-driven platform for strategic operating investments. Revenue has contracted sharply from $161.5M in FY2023 to $6.5M in FY2025, contributing to a 1-year stock decline of 93.6%. The company holds $49.7M in cash and short-term investments as of June 30, 2026.
- Market cap
- $24.0M
- Revenue (TTM)
- $12.8M
- P/E
- 0.0x
- 1Y return
- -93.6% S&P 500 16.8%
- Avg. target
- —
Bull case
- The company held $49.7M in cash and short-term investments as of June 30, 2026, which exceeded its enterprise value of $31.0M.
- SRXH traded at a price to book ratio of 0.2x and a price to sales ratio of 0.3x, below the US-listed Consumer Defensive median price to sales ratio of 0.7x.
- The balance sheet showed strong short-term liquidity with a current ratio of 27.55 as of June 30, 2026.
Bear case
- Annual revenue dropped from $161.5M in FY2023 to $6.5M in FY2025, resulting in a net loss of $45.0M.
- The company's share count increased 103718.2% over a 5-year span.
- The stock posted a 1-year return of -93.6% compared to a 16.8% gain for the S&P 500 benchmark.
What SRx Health Solutions does
SRX Global Inc. operates an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. It leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across various sectors. The company is based in North Palm Beach, Florida.
Growth and profitability
Annual revenue grew from $58.6M in FY2021 to $161.5M in FY2023, before falling 68.9% to $50.3M in FY2024 and falling 87.0% to $6.5M in FY2025. Over the 5-year period from FY2020 to FY2025, revenue posted a compound annual growth rate of -34.5%. Net income declined from $3.8M in FY2021 to -$45.0M in FY2025, with an operating margin of -174.6% and a net margin of -688.8%. In the trailing twelve months ended June 30, 2026, revenue stood at $12.8M, with quarterly revenue growth falling 9.4% year-over-year and an operating margin of -94.4%.
Balance sheet and cash flow
As of June 30, 2026, SRx Health Solutions held $49.7M in cash and short-term investments, total assets of $145.4M, and shareholders' equity of $143.0M. The company reported a current ratio of 27.55. For FY2025, operating cash flow was -$8.1M and free cash flow was -$8.1M. Capital allocation in FY2025 included capital expenditures of $2.1M and share buybacks of $137,000, while the 5-year share count change was 103718.2%.
Valuation and performance
At a last close of $1.19 on October 16, 2026, SRXH had a market cap of $24.0M and an enterprise value of $31.0M. The stock traded at an EV to EBITDA multiple of 5.2x and a price to sales ratio of 0.3x, compared to medians of 11.7x and 0.7x for its US-listed Consumer Defensive peers. Over the past year, SRXH delivered a return of -93.6%, lagging the S&P 500 (SPY) return of 16.8%, and traded at 78.8% below its 200-day average.
What analysts expect
Analysts recorded 0 EPS beats over the last 4 quarters. The stock closed at $1.19 on October 16, 2026, near its 52-week low of $0.96 and below its 52-week high of $42.60. Trailing twelve-month diluted EPS was reported at $62.19.
Key risks and what to watch
- Free cash flow has remained negative in four of the last five reported fiscal years, reaching -$8.1M in FY2025.
- Trailing twelve-month operating margin stood at -94.4%, below the US-listed Consumer Defensive peer median of 9.8%.
- Short interest accounted for 8.2% of the float as of October 16, 2026.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this SRXH AI stock analysis
This page is an AI-written research summary of SRx Health Solutions Inc. (SRXH). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: SRXH income statement, SRXH balance sheet, SRXH key metrics, SRXH chart. See the SRXH stock overview for the latest quote and news.
SRXH AI stock analysis FAQ
What is SRXH's cash position?
As of June 30, 2026, the company held $49.7M in cash and short-term investments, with a current ratio of 27.55.
Does SRXH pay a dividend?
No dividend payments are reported for SRXH.
How has SRXH stock performed over the past year?
SRXH generated a 1-year return of -93.6% through October 16, 2026, underperforming the S&P 500 (SPY) return of 16.8%.
What was SRx Health Solutions' revenue in FY2025?
In FY2025, revenue was $6.5M, down 87.0% compared to $50.3M in FY2024.